In the current landscape of 2026, The Veracity Group is seeing a tectonic shift in how federal agencies regulate the relationship between massive health systems and independent clinics. For years, smaller practices have been squeezed by "must-have" hospital systems that use their market leverage to dictate terms, often leading to extended payer enrollment timelines and complex administrative hurdles. However, a series of aggressive federal actions beginning in early 2026 has signaled that the days of "all-or-nothing" contracting and anti-steering clauses are numbered. This crackdown isn't just about big hospitals; it is a direct attempt to level the playing field for independent practices that have long struggled against consolidation-driven pricing and restrictive payer networks.
1. The DOJ’s Early 2026 Offensive: Targeting Hospital Giants
The Department of Justice (DOJ) has moved past simple warnings and into active litigation. In early 2026, the DOJ filed landmark antitrust lawsuits against OhioHealth on February 20 and NewYork-Presbyterian (NYP) on March 26, alleging that these systems used their "must-have" status to pressure insurers into anti-competitive contracts.
At the core of the DOJ’s complaints are practices commonly described as "all-or-nothing" networks. In these arrangements, a hospital system forces an insurer to include every single one of its facilities in every plan: even the high-priced, underperforming ones: if the insurer wants access to the system's flagship hospitals. For an independent practice, this means you are often competing against a bloated system that has essentially "locked in" its patient base through contractual force rather than clinical value. By challenging these mandates, the DOJ is opening doors for insurers to build narrower, high-value networks that prioritize efficient, independent providers over expensive, consolidated systems.
2. The FTC’s New Healthcare Task Force: A Guardian for Independent Clinics
Coinciding with the DOJ’s lawsuits, the Federal Trade Commission (FTC) launched its Healthcare Task Force in late March 2026. This isn't just another bureaucratic committee; it is a rapid-response unit designed to protect patients and independent practices from the fallout of vertical integration and private equity "roll-ups."
The task force is explicitly looking at how consolidation-driven pricing ruins the financial viability of independent groups. When a large system buys up local competitors, they often implement "anti-tiering" clauses. These clauses prevent insurers from placing the system in a lower-cost tier for patients, effectively neutralizing any price competition an independent clinic might offer. The FTC's new mandate is to dismantle these barriers, ensuring that if your clinic provides better value, the payer contract actually allows the patient to see that benefit.
3. The Emerging 25-35% Threshold: Why Even Moderate Market Power is Now Under Fire
Historically, the DOJ only pursued systems that held a dominant 50% or 60% of a local market. That changed this year. Federal regulators are increasingly scrutinizing systems with as little as 25% to 35% market share if their contracts hinder lower-cost plans. This is best understood as an emerging analytical threshold regulators are watching, not a codified legal rule.
This shift is a massive win for independent practices. It recognizes that in many regions, a system doesn't need to own the entire city to exert "must-have" leverage. If a system is the only major provider in a specific sub-market (like Manhattan or Columbus), they can effectively block insurers from offering budget-conscious plans that would otherwise favor independent doctors. The federal government's new stance is clear: market power is measured by leverage, not just percentages. If a contract prevents a payer from steering patients to your independent practice based on price and quality, that contract is now a target for federal intervention.
4. Transparency and the End of "Gag Clauses"
One of the most insidious tools used in payer contracts is the transparency gag clause. These clauses have historically prevented independent practices and patients from seeing the real negotiated rates of care. By keeping costs hidden, large systems can charge supracompetitive prices without fear of being undercut by a more efficient independent rival.
The 2026 federal crackdown emphasizes that these gag clauses are a direct violation of the Consolidated Appropriations Act. Plans are now required to submit an annual Gag Clause Prohibition Compliance Attestation (GCPCA) to CMS. A reasonable reading of current enforcement trends is that these attestations are becoming a more important tool for federal oversight and a growing area of scrutiny when systems resist transparency. For your practice, this means more visibility into market rates, helping you negotiate fairer terms during your payer enrollment process.
5. Action Steps for Independent Practices: Review Your Contracts
The federal government is doing its part, but independent practices must remain vigilant to protect their revenue. Revenue cycle delays often stem from the very contract clauses the DOJ is now fighting. You must review your existing and upcoming payer contracts for these specific "red flag" terms:
- Anti-Steering Clauses: Do your contracts include restrictions commonly described as anti-steering, where insurers are prevented from offering lower copays to patients who choose your clinic over a larger hospital system?
- Anti-Tiering Clauses: Are you being unfairly grouped into tiers that don't reflect your actual cost-efficiency?
- Non-Compete and Referral Restrictions: Are there hidden terms that penalize you for referring patients to other independent specialists?
Identifying these clauses is the first step toward how to avoid payer rejections and ensuring your practice isn't being sidelined by a dominant system's legal team.
6. The Veracity Group: Your Partner in a Changing Market
Navigating the complexities of federal healthcare law and payer contracting is a full-time job: one that most clinic owners don't have time for. Clinic onboarding challenges are often exacerbated by these anti-competitive environment shifts, making it harder than ever to get new providers credentialed and billing.
As reported by Modern Healthcare, the aggressive posture of the DOJ is driving a strategic shift in how payers evaluate and redesign their networks. This creates a chaotic environment where an application that worked last month might be rejected today due to a change in network "tiering" rules.
The Veracity Group serves as your expert partner in this volatile market. We don't just fill out forms; we understand the strategic shifts happening at the federal level. Whether you are dealing with Aetna health plans or BCBS networks, we ensure your practice is positioned to benefit from these new transparency rules rather than being buried by them.
Conclusion: A New Era of Competition
The federal proposals of 2026 represent a once-in-a-generation opportunity for independent practices to reclaim their market share. By dismantling "all-or-nothing" mandates and ending the era of gag clauses, the DOJ and FTC are providing a "passport to success" for clinics that can demonstrate true value. However, the high cost of delays in this new environment is real. If your practice isn't proactive in its enrollment and contract management, you will remain at the mercy of the systems the government is trying to regulate.
Looking for professional provider credentialing services in the USA?
👉 Check our main service page here: veracityeg.com
#PayerContracts #HealthcareAntitrust #DOJ #FTC #IndependentPractice #MedicalBilling #HealthcareCompliance #PayerEnrollment #CredentialingServices #TheVeracity Group #HealthcareLaw #RevenueCycleManagement #ClinicManagement #AntiCompetitive #MarketPower #Transparency #HealthcareReform2026 #MedicalPracticeGrowth #IndependentPhysicians #HealthcareAdvocacy #ProviderEnrollment #InsuranceNegotiations #GagClauses #AllOrNothingNetworks #HealthSystemConsolidation
